XTAI
4148
Market cap68mUSD
Sep 17, Last price
32.50TWD
1D
-1.22%
1Q
5.35%
IPO
-55.54%
Name
All Cosmos Bio-Tech Holding Corp
Chart & performance
P/E
14.28
P/S
0.74
EPS
2.28
Div yield, %
1.54%
Shrs. gr., 5y
7.12%
Rev. gr., 5y
12.41%
Revenues
2.95b
+19.95%
Net income
153m
+18.98%
CFO
252m
+364.93%
Dividend
Jul 08, 20261 TWD/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
All Cosmos Bio-Tech Holding Corporation, through its various operating units, primarily focuses on the production and distribution of bio-organic and bio-chemical compound fertilizers across Malaysia. The company also dedicates efforts to the research and development of microorganisms, particularly for the sustainable management of oil palm waste. Furthermore, it engages in the bulk supply of probiotics. Its activities extend to forest management and associated research initiatives. Internationally, All Cosmos Bio-Tech exports its various offerings to markets including Taiwan, Indonesia, Vietnam, and China. The corporation was established in 1999 and maintains its head office in George Town, Cayman Islands.
Key people
Jingwei Shi
Chief Financial Officer · since 2016
Chuifeng Lin
General Manager-Operation Division · since 2017
Shih Hao Peng
Chairman of the Board, Chief Executive Officer, General Manager · since 2012
Shengqing Peng
Director · since 2012
Jialin Peng
Director · since 2014
Genzai Xu
Director · since 2012
Luzhang Zhang
Director · since 2012
Qianhai Zhu
Director · since 2014
Wenquan Li
Independent Director · since 2019
Ziwu Luo
Independent Director · since 2012
Yongcheng Yang
Independent Director · since 2014
Valuation
Title TWD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||